Search

everythinglearnresearchcommunity

for

Search:↓

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

PTHrP and its receptor can control blood vessel growth and hair development in mouse skin.

Mice lacking fibromodulin have disrupted healing patterns, leading to abnormal skin repair and scarring.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Hairless protein can both repress and activate vitamin D receptor functions, affecting gene regulation.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

A single amino acid change in the vitamin D receptor can disrupt its function and lead to hair loss.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

Scientists identified a group of human skin cells with high growth and regeneration potential.

New mutations in the VDR gene cause vitamin D-resistant rickets without hair loss.

Longer CAG repeats in gene linked to more severe hair loss in females.

MC4R gene variants not linked to female hair loss.

Higher levels of the DP2 receptor may lead to hair loss.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

GLP-1RA therapy may increase the risk of hair loss.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

New compounds may help treat prostate cancer by reducing cell growth.

Pulsed red light boosts collagen and energy in cells faster than continuous red light.

The vitamin D receptor helps maintain hair and bone health even without binding vitamin D.

Vitamin D3 and its receptor are important for hair growth, and understanding receptors could help treat hair graying and skin cancer.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.